JPH08149974A - Bacterium-multiplying culture medium for pcr - Google Patents
Bacterium-multiplying culture medium for pcrInfo
- Publication number
- JPH08149974A JPH08149974A JP6296497A JP29649794A JPH08149974A JP H08149974 A JPH08149974 A JP H08149974A JP 6296497 A JP6296497 A JP 6296497A JP 29649794 A JP29649794 A JP 29649794A JP H08149974 A JPH08149974 A JP H08149974A
- Authority
- JP
- Japan
- Prior art keywords
- pcr
- bacterium
- medium
- pcr reaction
- multiplying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、PCR用増菌培地に関
する。FIELD OF THE INVENTION The present invention relates to a culture medium for PCR.
【0002】[0002]
【従来の技術】細菌のDNA鎖には、その細菌に特有の
DNA構成部分が含まれるのが一般的である。そこで、
DNA鎖の特有DNA構成部分の両端(開始端と終了
端)に二つのプライマー(一種のカギ)をとりつけ、D
NAポリメラーゼの作用で、両プライマーに挟まれた部
位のDNAを複写して多量に生産することを特徴とす
る、いわゆるPCR法は、細菌の遺伝子DNA鎖中その
細菌に特有なDNA(構成部分)を多量に複写(複製)
する処理を施した後、その特有DNAが検出されるか否
かにより、その細菌の有無を検査する細菌の同定法に利
用できる。このPCR法においては、通常培地でその細
菌の増殖処理を施してからその菌を遠心分離法や膜分離
法などにより集め、これを蒸留水や緩衝液に懸濁して、
この懸濁液をPCR用反応液に添加し、これをPCRサ
ーマルサイクレーターにかけて目的とするDNA構成部
分の複製処理を施すのが一般的である。集菌処理により
細菌を培地から分離するのは、細菌を培地ごとPCR用
反応液に添加したのではPCR反応が阻害されることが
多いからである。2. Description of the Related Art Generally, a DNA chain of a bacterium contains a DNA component specific to the bacterium. Therefore,
Attach two primers (a kind of key) to both ends (start end and end end) of the unique DNA constituent part of the DNA chain, and
The so-called PCR method, which is characterized in that the DNA at the site sandwiched by both primers is copied and produced in large quantities by the action of NA polymerase, is a DNA (component) that is unique to the bacterium in the gene DNA chain of the bacterium. Copy in large quantities (reproduction)
After carrying out the treatment described above, it can be used in a method for identifying a bacterium for inspecting the presence or absence of the bacterium depending on whether or not the specific DNA is detected. In this PCR method, after subjecting the bacteria to growth treatment in a normal medium, the bacteria are collected by a centrifugation method, a membrane separation method or the like, suspended in distilled water or a buffer solution,
It is general that this suspension is added to a reaction solution for PCR, and this is subjected to a PCR thermal cycler to carry out a replication treatment of a target DNA constituent part. The reason why the bacteria are separated from the medium by the cell-harvesting treatment is that the addition of the bacteria together with the medium to the PCR reaction solution often inhibits the PCR reaction.
【0003】[0003]
【発明が解決しようとする課題】しかし、前記の集菌作
業は手間がかかり煩雑である。本発明の目的は、細菌の
増殖処理を施した培地を直接PCR用反応液に添加した
場合でも、PCR反応が阻害されないようなPCR用増
菌培地を提供することである。However, the above-mentioned work of collecting bacteria is troublesome and complicated. An object of the present invention is to provide a PCR-enriched culture medium in which the PCR reaction is not inhibited even when the culture medium subjected to bacterial growth treatment is directly added to the PCR reaction solution.
【0004】[0004]
【課題を解決するための手段】本発明者は、上記目的を
達成するために種々検討した結果本発明に到達した。す
なわち、本発明のPCR用増菌培地は、リン酸塩を含ま
ないことを特徴とする。The present inventor has arrived at the present invention as a result of various studies for achieving the above object. That is, the PCR enrichment medium of the present invention is characterized by not containing phosphate.
【0005】以下、本発明を詳細に説明する。なお、本
発明において「%」はすべて「重量%」を意味する。ま
ず、本発明のPCR用増菌培地は、菌の増殖用に用い、
しかも増菌した後の培地(液)をPCR用反応液に直接
添加することのできる培地をいう。直接添加した場合に
PCR反応が阻害されるような培地は、本発明でいうP
CR用増菌培地とはならない。本発明のPCR用増菌培
地は、具体的にはペプトンなどの窒素原料、塩類(塩化
ナトリウムなど)、緩衝剤などから構成される。この培
地には、ブドウ糖、酵母エキスなどの栄養成分や、検査
したい菌以外の菌の増殖を阻害する薬剤(選択的菌阻害
剤)、例えば、ナリジキシ酸、アクリフラビン塩酸塩、
クリスタルバイオレット、ブリリアントグリーンなどを
任意に加え得る。また、通常培地には何らかの意味でp
H調整用に緩衝剤を加える。緩衝剤としては、TRIS
(Tris aminomethane )、HEPES(N-2-hydroxyeth
ylpiperazinesurufonic acid)、MOPS(N-morpholi
no propanesulfonic acid )などがあげられる。The present invention will be described in detail below. In the present invention, all "%" mean "% by weight". First, the PCR enrichment medium of the present invention is used for the growth of bacteria,
Moreover, it refers to a medium that can be directly added to the PCR reaction solution after enrichment. A medium that inhibits the PCR reaction when added directly is used as P in the present invention.
It does not serve as a CR enrichment medium. Specifically, the PCR enrichment medium of the present invention is composed of a nitrogen raw material such as peptone, salts (such as sodium chloride), and a buffer. In this medium, nutrients such as glucose and yeast extract, and agents that inhibit the growth of bacteria other than the bacteria to be tested (selective bacteria inhibitors), for example, nalidixic acid, acriflavine hydrochloride,
Crystal violet, brilliant green, etc. may optionally be added. In addition, p is somehow
Add buffer for H adjustment. As a buffer, TRIS
(Tris aminomethane), HEPES (N-2-hydroxyeth
ylpiperazinesurufonic acid), MOPS (N-morpholi
no propanesulfonic acid) and the like.
【0006】リン酸塩は代表的な緩衝剤であるが、本発
明の培地はこれは含まない。リン酸塩を含むと、増菌し
たあとの培地をそのままPCR用反応液に添加して使用
したときに、PCR反応が阻害されるからである。緩衝
剤で培地のpHを調整するが、pHは通常目的の細菌の
増殖に最適な値に合わせる。Phosphate is a typical buffering agent, but the medium of the present invention does not include it. This is because the inclusion of phosphate inhibits the PCR reaction when the medium after the bacterium enrichment is added as it is to the PCR reaction solution and used. The pH of the medium is adjusted with a buffer, and the pH is usually adjusted to the optimum value for the growth of the desired bacteria.
【0007】本発明のPCR用増菌培地は、PCR法に
使用する目的で、検査したい菌を増殖する培地として使
用する。The enrichment medium for PCR of the present invention is used as a medium for growing the bacteria to be inspected for the purpose of use in the PCR method.
【0008】[0008]
【作用】本発明のPCR用増菌培地は、これをPCR反
応液に直接添加してもPCR反応が阻害されないが、そ
の作用は定かではない。The PCR-enriched culture medium of the present invention does not inhibit the PCR reaction when it is directly added to the PCR reaction solution, but its action is not clear.
【0009】以下、本発明の実施例および試験例を説明
する。Examples and test examples of the present invention will be described below.
実施例1 下記の配合からなるサルモネラ菌のPCR用増菌培地 原料の種類 配合割合 ペプトン 10.0g/l(リットル) 塩化ナトリウム 5.0g/l TRIS 6.5g/l (pH 7.2) Example 1 Enrichment medium for PCR of Salmonella consisting of the following formulation Type of raw material Blending ratio Peptone 10.0 g / l (liter) Sodium chloride 5.0 g / l TRIS 6.5 g / l (pH 7.2)
【0010】実施例2 下記の配合からなるサルモネラ菌のPCR用増菌培地 原料の種類 配合割合 ペプトン 10.0g/l 塩化ナトリウム 5.0g/l HEPES 10.5g/l (pH 7.2)Example 2 Enrichment medium for PCR of Salmonella having the following formulation Type of raw material Blending ratio Peptone 10.0 g / l Sodium chloride 5.0 g / l HEPES 10.5 g / l (pH 7.2)
【0011】実施例3 下記の配合からなるサルモネラ菌のPCR用増菌培地 原料の種類 配合割合 ペプトン 10.0g/l 塩化ナトリウム 5.0g/l MOPS 11.9g/l (pH 7.2)Example 3 Enrichment medium for PCR of Salmonella having the following composition: Type of raw material Mixing ratio Peptone 10.0 g / l Sodium chloride 5.0 g / l MOPS 11.9 g / l (pH 7.2)
【0012】実施例4 下記の配合からなる毒素原性大腸菌のPCR用増菌培地 原料の種類 配合割合 ペプトン 10.0g/l 乳糖 10.0g/l 塩化ナトリウム 5.0g/l TRIS 3.0g/l (pH 7.3)Example 4 Enrichment medium for PCR of toxigenic Escherichia coli consisting of the following formulation Type of raw material Blending ratio Peptone 10.0 g / l Lactose 10.0 g / l Sodium chloride 5.0 g / l TRIS 3.0 g / l (pH 7.3)
【0013】実施例5 下記の配合からなるリステリア菌のPCR用増菌培地 原料の種類 配合割合 ペプトン 5.0g/l トリプトン 5.0g/l 酵母エキス 5.0g/l 塩化ナトリウム 20.0g/l TRIS 15.0g/l ナリジキシ酸 20 mg/l(選択的菌阻害剤) アクリフラビン塩酸塩 12.mg/l(選択的菌阻害剤) (pH 7.2)Example 5 Enrichment medium for PCR of Listeria monocytogenes having the following formulation Type of raw material Blending ratio Peptone 5.0 g / l Tryptone 5.0 g / l Yeast extract 5.0 g / l Sodium chloride 20.0 g / l TRIS 15.0 g / l nalidixic acid 20 mg / l (selective bacterium inhibitor) acriflavine hydrochloride 12. mg / l (selective bacterium inhibitor) (pH 7.2)
【0014】[0014]
<試験方法>121℃で殺菌した3種の倍地(実施例1
〜3)の各々について、ゲルトネル菌(Salmonella cho
lerae serovar Enteritidis )を2.8×10個/ml
となるように植菌し、35℃で16時間培養した後、1
00℃で10分間加熱して殺菌した。この殺菌済み培地
(液)をPCR法を用いた試験に供してゲルトネル菌に
特有なDNA構成部分の有無を検査した。比較のため、
リン酸塩含有の増菌用培地についても、上記と同じ処理
をした。<Test method> Three types of medium sterilized at 121 ° C (Example 1
~ 3) for each of the
lerae serovar Enteritidis) 2.8 × 10 / ml
And incubate at 35 ° C for 16 hours, then
It sterilized by heating at 00 degreeC for 10 minutes. This sterilized medium (liquid) was subjected to a test using the PCR method to examine the presence or absence of a DNA component peculiar to Gertonel bacterium. For comparison,
The same treatment as described above was performed on the phosphate-containing culture medium for enrichment.
【0015】<試験結果>下表のとおりとなった。すな
わち、本発明のリン酸塩を含まない培地では細菌特有な
DNA構成部分が検出されたのに対して、リン酸塩を含
む培地では特有なDNA構成部分が検出されなかったこ
とから、PCR反応が円滑に進行していないことが理解
できる。<Test Results> The results are shown in the table below. That is, the DNA component specific to the bacterium was detected in the phosphate-free medium of the present invention, whereas the specific DNA component was not detected in the phosphate-containing medium. It can be understood that is not progressing smoothly.
【0016】 <試験結果表> 本発明 比較例 試料No. 1 2 3 4 項 目 (実施例1)(実施例2)(実施例3) −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− 殺菌前の 培地中の菌の濃度 2.3 3.6 2.3 3.0 (個/ml) ×108 ×108 ×108 ×108 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−− 検出の有(○) 無(×) ○ ○ ○ × −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−<Test Result Table> Present Invention Comparative Example Sample No. 1 2 3 4th item (Example 1) (Example 2) (Example 3) -------------------------- --- Concentration of bacteria in medium before sterilization 2.3 3.6 2.3 3.0 (cells / ml) x 10 8 x 10 8 x 10 8 x 10 8 -------- −−−−−−−−−−−−−−−−−−−−− Detection Yes (○) No (x) ○ ○ ○ × −−−−−−−−−−−−−−− −−−−−−−−−−−−−−−−−
【0017】注1)PCR法を用いた試験法は下記によ
った。下記の配合でPCR用反応液を調製し、これをP
CRサーマルサイクレーターにかけて目的のDNA構成
部分を増加し、これをゲル電気泳動法により分離し、そ
のDNA構成部分の有無を判定する。Note 1) The test method using the PCR method was as follows. Prepare a reaction solution for PCR with the following formulation and add it to P
The target DNA component is increased by applying a CR thermal cyclizer, and this is separated by gel electrophoresis to determine the presence or absence of the DNA component.
【0018】 <PCR反応液の配合> 菌液(培養後殺菌した培地) 5.0μl(マイクロリットル) 水 23.5μl PCR用緩衝液 5.0μl 25mM塩化マグネシウム 3.0μl プライマー1 5.0μl プライマー2 5.0μl dNTP混合液 3.0μl Taqポリメラーゼ 0.5μl<Blending of PCR reaction solution> Bacterial fluid (medium sterilized after culturing) 5.0 μl (microliter) Water 23.5 μl PCR buffer 5.0 μl 25 mM magnesium chloride 3.0 μl Primer 1 5.0 μl Primer 2 5.0 μl dNTP mixed solution 3.0 μl Taq polymerase 0.5 μl
【0019】<PCRサーマルサイクレーターでの処理
条件> (90℃×1分、50℃×1分、72℃×1分)×30
サイクル<Treatment conditions in PCR thermal cycler> (90 ° C. × 1 minute, 50 ° C. × 1 minute, 72 ° C. × 1 minute) × 30
cycle
【0020】注2)比較例としたリン酸塩含有培地の配
合は下記のとおり 原料の種類 配合割合 ペプトン 10.0g/l 塩化ナトリウム 5.0g/l リン酸二ナトリウム 3.5g/l リン酸一カリウム 1.5g/l (pH 7.2)Note 2) The composition of the phosphate-containing medium used as a comparative example is as follows: Type of raw material Mixing ratio Peptone 10.0 g / l Sodium chloride 5.0 g / l Disodium phosphate 3.5 g / l Phosphoric acid Monopotassium 1.5g / l (pH 7.2)
【0021】[0021]
【発明の効果】以上述べたように、本発明のPCR用増
菌培地を使用すれば、増菌した後の培地を直接PCR用
反応液に添加してもPCR反応が阻害されず、したがっ
て、PCR反応に移る前の集菌処理などの煩雑な手間を
解消することができる。As described above, when the PCR-enriched culture medium of the present invention is used, the PCR reaction is not inhibited even when the culture medium after the bacterial culture is added directly to the PCR reaction solution, and therefore, It is possible to eliminate the troublesome work such as the bacteria collection process before proceeding to the PCR reaction.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 (C12N 1/20 C12R 1:01) ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification number Office reference number FI technical display location (C12N 1/20 C12R 1:01)
Claims (2)
CR用増菌培地。1. P that is free of phosphate
CR enrichment medium.
またはMOPSを含む請求項1記載のPCR用増菌培
地。2. TRIS, HEPES as a pH buffering agent
Alternatively, the enrichment medium for PCR according to claim 1, which contains MOPS.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6296497A JPH08149974A (en) | 1994-11-30 | 1994-11-30 | Bacterium-multiplying culture medium for pcr |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6296497A JPH08149974A (en) | 1994-11-30 | 1994-11-30 | Bacterium-multiplying culture medium for pcr |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH08149974A true JPH08149974A (en) | 1996-06-11 |
Family
ID=17834322
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6296497A Pending JPH08149974A (en) | 1994-11-30 | 1994-11-30 | Bacterium-multiplying culture medium for pcr |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH08149974A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017176469A1 (en) * | 2016-04-08 | 2017-10-12 | 3M Innovative Properties Company | Process for cell lysis and nucleic acid amplification |
US10604787B2 (en) | 2014-12-23 | 2020-03-31 | 3M Innovative Properties Company | Composition for reducing inhibition of nucleic acid amplification |
-
1994
- 1994-11-30 JP JP6296497A patent/JPH08149974A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10604787B2 (en) | 2014-12-23 | 2020-03-31 | 3M Innovative Properties Company | Composition for reducing inhibition of nucleic acid amplification |
WO2017176469A1 (en) * | 2016-04-08 | 2017-10-12 | 3M Innovative Properties Company | Process for cell lysis and nucleic acid amplification |
CN109072286A (en) * | 2016-04-08 | 2018-12-21 | 3M创新有限公司 | The method of cell cracking and nucleic acid amplification |
JP2019517778A (en) * | 2016-04-08 | 2019-06-27 | スリーエム イノベイティブ プロパティズ カンパニー | Process for cell lysis and nucleic acid amplification |
US11168352B2 (en) | 2016-04-08 | 2021-11-09 | 3M Innovative Properties Company | Process for cell lysis and nucleic acid amplification |
CN109072286B (en) * | 2016-04-08 | 2023-08-11 | 3M创新有限公司 | Method for cell lysis and nucleic acid amplification |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0871854B1 (en) | Medium for detecting enterococci in a sample | |
Hirota et al. | A mutant of Escherichia coli defective in DNA polymerase II activity | |
Martins et al. | Distribution of uidA gene sequences in Escherichia coli isolates in water sources and comparison with the expression of beta-glucuronidase activity in 4-methylumbelliferyl-beta-D-glucuronide media | |
Ng et al. | Specific detection and confirmation of Campylobacter jejuni by DNA hybridization and PCR | |
EP1370694B1 (en) | Detection of methicillin-resistant staphylococcus aureus (mrsa) | |
JP2005160491A (en) | Culture and specific identification medium for different kinds of candida, and analysis method | |
EP3280821B1 (en) | Detection of one or more pathogens | |
Buesching et al. | Enhanced primary isolation of Legionella pneumophila from clinical specimens by low-pH treatment | |
Kerbiriou et al. | Biosynthesis of an aspartate transcarbamylase lacking co-operative interactions: I. Disconnection of homotropic and heterotropic interactions under the influence of 2-thiouracil | |
Rodriguez-Lazaro et al. | Rapid quantitative detection of Listeria monocytogenes in salmon products: Evaluation of Pre–Real-Time PCR strategies | |
KR20120021269A (en) | Enrichment of listeria spp | |
CA3130726A1 (en) | Selective enrichment broth for detection of one or more pathogens | |
AU728893B2 (en) | Process for detecting live microbiological contaminants in food product sample | |
JPH08149974A (en) | Bacterium-multiplying culture medium for pcr | |
US5650290A (en) | Method & Medium for use in detecting E. coli and total coliforms | |
Johnson | Isolation and identification of pathogenic Yersinia enterocolitica from meat and poultry products | |
West et al. | recA+-dependent inactivation of the lambda repressor in Escherichia coli lysogens by γ-radiation and by tif expression | |
Olsen et al. | Evidence for the evolution of a single component phenol/cresol hydroxylase from a multicomponent toluene monooxygenase | |
WO1995032304A1 (en) | Method for the rapid separation and identification of microbial contaminants from a complex matrix | |
Torres et al. | Differentiation of Neisseria gonorrhoeae from other Neisseria species by use of the restriction endonuclease HaeIII | |
Farber | Potential use of membrane filters and a fluoregenic reagent-based solid medium for the enumeration of Escherichia coli in foods | |
Adler et al. | Properties of Escherichia coli mutants with alterations in Mg2+-adenosine triphosphatase | |
JP2003509067A (en) | Nucleotide sequence derived from the gene encoding trimethylamine N-oxidoreductase, and its use especially for bacterial detection | |
JP2008048670A (en) | Method for simultaneously culturing food poisoning bacteria, and method for detecting them | |
Kodjo et al. | Identification of Moraxella bovis and related species from calves with IBK and goats by qualitative genetic transformation assay |